| ADMET | Absorption, distribution, metabolism, excretion and toxicity |
| BTs | Bloodstream trypomastigotes |
| Bz | Benznidazole |
| CCs | Cultures of cardiac cells |
| EC50 | Compound concentration that reduces 50% of the number of parasites |
| EC90 | Compound concentration that reduces 90% of the number of parasites |
| CD | Chagas disease |
| CDCl3 | Deuterated chloroform |
| CEUA | Committee of Ethics for the Use of Animals |
| COSY | Homonuclear correlation spectroscopy |
| DEPT | Distortionless enhancement by polarization transfer |
| DMSO | Dimethyl sulfoxide |
| DTUs | Discrete typing units |
| FBS | Fetal bovine serum |
| FDA | Food and Drug Administration |
| FICI | Fractional inhibitory concentrations index |
| hERG | Human ether-à-go-go-related gene |
| HMBC | Heteronuclear multiple bond correlation |
| HSQC | Heteronuclear single quantum coherence |
| LC50 | The concentration that kills 50% of the parasite |
| Nf | Nifurtimox |
| NMR | Nuclear magnetic resonance |
| OsO4 | Osmium tetroxide |
| Pb | Plumbagin |
| P-gp | P-glycoprotein |
| pKCSM | Small-molecule pharmacokinetic and toxicity properties |
| SEM | Scanning electron microscopy |
| SIs | Selectivity indexes |
| T. cruzi | Trypanosoma cruzi |
| TEM | Transmission electron microscopy |
| TMS | Tetramethylsilane |
| ΣFICIs | Sum of fractional inhibitory concentration indexes |
| µg/mL | Micrograms per milliliter |
| μM | Micromolar |